PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • PDR Drug Communications are designed to improve the speed and efficacy of the delivery of PDR Drug Alerts, Recalls and Approvals to physicians, prescribers, and their staff.

    Below are the PDR Drug Communications that have been issued by PDR Network. To view the communication details, click on the Medication name.

    If you have trouble accessing Alert details, click to get the latest version of the free Adobe Acrobat Reader software for your computer.

    Filter results by:

    Results 1-20 of 113

    July 15, 2021 Drug Alert: Important Prescribing Information

    Valcyte® (valganciclovir)

    Genentech, Inc.

    May 07, 2021 Drug Alert: Important Prescribing Information

    Tecentriq® (atezolizumab)

    Genentech, Inc.

    March 19, 2021 Drug Alert: Important Prescribing Information

    Xeljanz® (tofacitinib)

    Pfizer

    March 15, 2021 Drug Alert: Important Drug Warning

    Mycophenolate

    Various Mycophenolate Applicants

    February 16, 2021 Drug Alert: Important Drug Warning

    Xeljanz® (tofacitinib)

    Pfizer

    February 08, 2021 Drug Alert: Important Drug Warning

    Xalkori® (crizotinib)

    Pfizer

    October 07, 2020 Drug Alert: Important Prescribing Information

    Xeljanz® (tofacitinib)

    Pfizer

    September 18, 2020 Drug Alert: Opioid Analgesics - FDA Required REMS for Serious Drug Risks

    Analgesic Opioids

    Various

    August 19, 2020 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Blenrep (belantamab mafodotin-blmf)

    GlaxoSmithKline LLC

    August 03, 2020 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Turalio™ (pexidartinib)

    Daiichi Sankyo, Inc.

    June 12, 2020 Drug Alert: Important Prescribing Information

    Actemra® (tocilizumab)

    Genentech, Inc.

    May 05, 2020 Drug Alert: Important Prescribing Information

    Actemra® (tocilizumab)

    Genentech, Inc.

    October 29, 2019 Drug Alert: Important Prescribing Information

    Xofluza® (baloxavir marboxil)

    Genentech, Inc.

    September 18, 2019 Drug Alert: Opioid Analgesics - FDA Required REMS for Serious Drug Risks

    Analgesic Opioids

    Various

    September 10, 2019 Drug Alert: Important Drug Warning

    Arikayce® (amikacin liposome inhalation suspension)

    Insmed Incorporated

    August 23, 2019 Drug Alert: FDA-REQUIRED REMS SAFETY INFORMATION

    Turalio™ (pexidartinib)

    Daiichi Sankyo, Inc.

    August 01, 2019 Drug Alert: Important Drug Warning

    Xeljanz® (tofacitinib)

    Pfizer, Inc.

    June 19, 2019 Drug Alert: Important Drug Warning

    Actemra® (tocilizumab)

    Genentech, Inc.

    May 17, 2019 Drug Alert: Important Drug Warning

    Jynarque™ (tolvaptan)

    Otsuka America Pharmaceutical Inc.

    Results 1-20 of 113